Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 26, 2022; 10(36): 13216-13226
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13216
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13216
Ref. | Reasons(s) for gap | Population | Results | Free text of gap |
Park et al[22] | D | Delta variant | A total of 141 patients [Delta group, n = 108 (77%); non-Delta group, n = 33 (23%)]; Delta group: Median age 34.5 (26.5-46.0); Hypertension 12 (11.1); Hyperlidemia 2 (6.1); Diabetes 5 (15.2); Psychiatric Illness 1(3.0); Asthma/Rhinitis 1 (3.0); Cancer 1 (3.0); Obesity BMI > 30.4 (12.1) | Results may not be applicable for reference as full vaccinated criteria not included and our subject only had chronic respiratory disease 1 (6.67) and obesity 1 (6.67) |
Hu et al[23] | D | Delta variant fully vaccinated | A total of 677 patients (Wild type = 341; Delta unvaccinated = 120; Delta Partially vaccinated = 60; Delta fully vaccinated = 156); Delta fully vaccinated: Median age 43.0 (33.0-56.8); Hypertension 31 (19.9); Diabetes 9 (5.8); Cardiovascular disease 5 (3.2) | Results may not be applicable for reference as median age in our subject 29.87 ± 5.097 with comorbidity chronic respiratory disease 1 (6.67) and obesity 1 (6.67) |
- Citation: Karuniawati A, Syam AF, Achmadsyah A, Ibrahim F, Rosa Y, Sudarmono P, Fadilah F, Rasmin M. Case series in Indonesia: B.1.617.2 (delta) variant of SARS-CoV-2 infection after a second dose of vaccine. World J Clin Cases 2022; 10(36): 13216-13226
- URL: https://www.wjgnet.com/2307-8960/full/v10/i36/13216.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i36.13216